Naznin Akhtar
Naznin Akhtar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Sikder M. Asaduzzaman
Institute of Tissue Banking and Biomaterial Research, Atomic Energy Research Establishment (AERE), Savar, Dhaka 1349, Bangladesh
6 shared publications - Md. Arifuzzaman
Institute of Tissue Banking and Biomaterial Research , Atomic Energy Research Establishment , Dhaka , 1349 , Bangladesh
3 shared publications - Ayesha Siddika
Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh
2 shared publications - Farzana Diba
Institute of Tissue Banking and Biomaterial Research Atomic Energy Research Establishment (AERE) Savar Dhaka-1349 Bangladesh
2 shared publications - Masud Rana
Institute of Tissue Banking and Biomaterial Research, Atomic Energy Research Establishment, Dhaka, Bangladesh
2 shared publications - Md. Liakat Hossain2 shared publications
Latest Publications
- 9 July 2024
- Published by Springer Nature in Journal of Materials Research
- Vol. 39 (15) , 2215-2227
Development of nanoparticle doped hydroxyapatite-based composite scaffolds for maxillofacial reconstruction
- 9 July 2024
- Published by Springer Nature in Journal of Materials Research
- Vol. 39 (15) , 2215-2227
Development of nanoparticle doped hydroxyapatite-based composite scaffolds for maxillofacial reconstruction
- 22 January 2024
- Published by Walter de Gruyter GmbH in Journal of Polymer Engineering
- Vol. 44 (3) , 211-222
Physically cross-linked scaffold composed of hydroxyapatite-chitosan-alginate-polyamide has potential to trigger bone regeneration in craniofacial defect
Recently, the fabrication of a scaffold from biomaterials has been increased due to the lack of adequate natural bone for grafting. In this study, hydroxyapatite-chitosan-alginate-polyamide (HCAP) synthetic scaffold was fabricated using the thermally induced phase separation (TIPS) technique. The scaffold was cross-linked with either a chemical cross-linker (calcium chloride, 2-hydroxyethyl methacrylate (HEMA), or glutaraldehyde (GTA)) or a physical cross-linker (gamma irradiation (IR)) resulting in scaffolds HCAP-CaCl2, HCAP-HEMA, HCAP-GTA, and HCAP-IR, respectively. The cross-linked scaffolds were characterized based on physicochemical properties, cytotoxicity, and biocompatibility. HCAP-GTA showed the highest density and the lowest swelling ratio and biodegradation rate closely matching with those of the HCAP-IR. Porosity and density of the HCAP, HCAP-IR, and HCAP-GTA scaffolds were 92.14, 87.26, and 83.33 %, and 0.241, 0.307, and 0.335 g/cm3, respectively. The swelling ratio for the same scaffolds was 149, 110, and 108 % after 72 h of observation. Brine shrimp cytotoxicity and RBC biocompatibility assay confirmed the non-toxic nature of HCAP-IR and HCAP-GTA scaffolds. The HCAP-IR scaffold was tested for bone regeneration in the rabbit mandible defect model. Histological analysis revealed the regeneration of new bone and restoration of bone defect at the site of injury. These findings indicate that radiation induced physically cross-linked HCAP scaffold could be used as an alternative in bone defect replacement therapy.
- 22 January 2024
- Published by Walter de Gruyter GmbH in Journal of Polymer Engineering
- Vol. 44 (3) , 211-222
Physically cross-linked scaffold composed of hydroxyapatite-chitosan-alginate-polyamide has potential to trigger bone regeneration in craniofacial defect
Recently, the fabrication of a scaffold from biomaterials has been increased due to the lack of adequate natural bone for grafting. In this study, hydroxyapatite-chitosan-alginate-polyamide (HCAP) synthetic scaffold was fabricated using the thermally induced phase separation (TIPS) technique. The scaffold was cross-linked with either a chemical cross-linker (calcium chloride, 2-hydroxyethyl methacrylate (HEMA), or glutaraldehyde (GTA)) or a physical cross-linker (gamma irradiation (IR)) resulting in scaffolds HCAP-CaCl2, HCAP-HEMA, HCAP-GTA, and HCAP-IR, respectively. The cross-linked scaffolds were characterized based on physicochemical properties, cytotoxicity, and biocompatibility. HCAP-GTA showed the highest density and the lowest swelling ratio and biodegradation rate closely matching with those of the HCAP-IR. Porosity and density of the HCAP, HCAP-IR, and HCAP-GTA scaffolds were 92.14, 87.26, and 83.33 %, and 0.241, 0.307, and 0.335 g/cm3, respectively. The swelling ratio for the same scaffolds was 149, 110, and 108 % after 72 h of observation. Brine shrimp cytotoxicity and RBC biocompatibility assay confirmed the non-toxic nature of HCAP-IR and HCAP-GTA scaffolds. The HCAP-IR scaffold was tested for bone regeneration in the rabbit mandible defect model. Histological analysis revealed the regeneration of new bone and restoration of bone defect at the site of injury. These findings indicate that radiation induced physically cross-linked HCAP scaffold could be used as an alternative in bone defect replacement therapy.
- Open Access
- 11 November 2023
- Published by Wiley in International Journal of Polymer Science
- Vol. 2023, 1-14
Effects of Gamma Irradiation on the Properties of Hydroxyapatite-Collagen-Chitosan-Mg-ZnO Scaffolds for Bone Tissue Engineering
Bone tissue engineering aims to repair diseased or damaged bone that cannot be regenerated naturally. This study is designed to develop biodegradable porous scaffolds as bone substitutes and evaluate the effect of gamma irradiation on these scaffolds for the restoration of defected bone. Here, composite scaffolds (HA-COL-CS-Mg-ZnO) were prepared by the thermally induced phase separation (TIPS) technique using collagen (COL) and chitosan (CS), hydroxyapatite (HA), magnesium (Mg), and zinc oxide (ZnO) at different mass ratios. Thereafter, the scaffolds were subjected to 10KGy γ-radiation for physical cross-linking and sterilization. The physicochemical and biological properties of the scaffolds were evaluated by Fourier transform infrared spectroscopy-attenuated total reflectance (FTIR-ATR), field emission scanning electron microscopy (FESEM), physical stability (biodegradability, swelling rate, porosity, and density), mechanical properties, biocompatibility, cytotoxicity, and antimicrobial activity against Escherichia coli (ATCC-25922) and Staphylococcus aureus (ATCC-25923). We found that the irradiated scaffold showed enhanced tensile strength and antimicrobial activities which are desirable characteristics of bone-mimicking scaffolds. FESEM revealed that the average pore size decreased from 192.3 to 104.5μm due to radiation. FTIR-ATR spectra showed that γ-radiation triggered cross-linking in the polymer matrix which improved mechanical strength (0.82N/mm2 to 1.86N/mm2) by increasing pore wall thickness. Moreover, the irradiated and nonirradiated scaffolds were biocompatible and noncytotoxic toward the Vero cell line which ensured their suitability for use in vivo. These results demonstrate that sterilization of HA-COL-CS-Mg-ZnO scaffolds with gamma-irradiation substantially improves the physicochemical and morphological features which aid bone tissue regeneration and could be supportive for new bone formation.
- 11 November 2023
- Published by Wiley in International Journal of Polymer Science
- Vol. 2023, 1-14
Open AccessEffects of Gamma Irradiation on the Properties of Hydroxyapatite-Collagen-Chitosan-Mg-ZnO Scaffolds for Bone Tissue Engineering
Bone tissue engineering aims to repair diseased or damaged bone that cannot be regenerated naturally. This study is designed to develop biodegradable porous scaffolds as bone substitutes and evaluate the effect of gamma irradiation on these scaffolds for the restoration of defected bone. Here, composite scaffolds (HA-COL-CS-Mg-ZnO) were prepared by the thermally induced phase separation (TIPS) technique using collagen (COL) and chitosan (CS), hydroxyapatite (HA), magnesium (Mg), and zinc oxide (ZnO) at different mass ratios. Thereafter, the scaffolds were subjected to 10KGy γ-radiation for physical cross-linking and sterilization. The physicochemical and biological properties of the scaffolds were evaluated by Fourier transform infrared spectroscopy-attenuated total reflectance (FTIR-ATR), field emission scanning electron microscopy (FESEM), physical stability (biodegradability, swelling rate, porosity, and density), mechanical properties, biocompatibility, cytotoxicity, and antimicrobial activity against Escherichia coli (ATCC-25922) and Staphylococcus aureus (ATCC-25923). We found that the irradiated scaffold showed enhanced tensile strength and antimicrobial activities which are desirable characteristics of bone-mimicking scaffolds. FESEM revealed that the average pore size decreased from 192.3 to 104.5μm due to radiation. FTIR-ATR spectra showed that γ-radiation triggered cross-linking in the polymer matrix which improved mechanical strength (0.82N/mm2 to 1.86N/mm2) by increasing pore wall thickness. Moreover, the irradiated and nonirradiated scaffolds were biocompatible and noncytotoxic toward the Vero cell line which ensured their suitability for use in vivo. These results demonstrate that sterilization of HA-COL-CS-Mg-ZnO scaffolds with gamma-irradiation substantially improves the physicochemical and morphological features which aid bone tissue regeneration and could be supportive for new bone formation.
- Open Access
- 15 October 2018
- Published by MDPI AG in Preprints.org
Human Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- 15 October 2018
- Published by MDPI AG in Preprints.org
Open AccessHuman Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- Open Access
- 15 October 2018
- Published by MDPI AG in Preprints.org
Human Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- 15 October 2018
- Published by MDPI AG in Preprints.org
Open AccessHuman Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- 25 February 2016
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 17 (2) , 189-197
Tissue banking in Bangladesh: 12 years of experience (2003–2014)
Tissue Banking and Biomaterial Research Unit (TBBRU), the only tissue bank of Bangladesh, has been established to create an available supply of human tissue allografts for transplantation in Bangladesh. Since its establishment in 2003, TBBRU strictly follows the guidelines of tissue banking setup by the International Atomic Energy Agency, the European Association of Tissue Banks and the American Association of Tissue Banks. Though started serving from earlier, regular supply of tissue allografts from this bank were documented at the end of 2006. From January 2007 to December 2014, 3747 bones and 5772 amniotic sacs were collected from live tissue donors. During this period, 59,489 cc bone allografts and 23,472 pieces of amniotic membrane allografts were processed. In the same period, 58,483 cc bone allografts and 20,786 pieces membrane were supplied to different hospitals throughout the country on the basis of demand. The outcomes of the concerted efforts of tissue banking professionals and physicians were the restoration of health and hope of 3662 patients during the last 8 years.
- 25 February 2016
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 17 (2) , 189-197
Tissue banking in Bangladesh: 12 years of experience (2003–2014)
Tissue Banking and Biomaterial Research Unit (TBBRU), the only tissue bank of Bangladesh, has been established to create an available supply of human tissue allografts for transplantation in Bangladesh. Since its establishment in 2003, TBBRU strictly follows the guidelines of tissue banking setup by the International Atomic Energy Agency, the European Association of Tissue Banks and the American Association of Tissue Banks. Though started serving from earlier, regular supply of tissue allografts from this bank were documented at the end of 2006. From January 2007 to December 2014, 3747 bones and 5772 amniotic sacs were collected from live tissue donors. During this period, 59,489 cc bone allografts and 23,472 pieces of amniotic membrane allografts were processed. In the same period, 58,483 cc bone allografts and 20,786 pieces membrane were supplied to different hospitals throughout the country on the basis of demand. The outcomes of the concerted efforts of tissue banking professionals and physicians were the restoration of health and hope of 3662 patients during the last 8 years.